Related Experiment Video
Updated: Mar 28, 2026

10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
3.3K
Human pluripotent stem cell based islet models for diabetes research.
Diego Balboa1, Timo Otonkoski2
1University of Helsinki, Research Programs Unit, Molecular Neurology and Biomedicum Stem Cell Center, Finland.
Best Practice & Research. Clinical Endocrinology & Metabolism
|December 24, 2015
Summary
Mouse models inadequately represent human pancreatic development and diabetes. Human pluripotent stem cells (hPSCs) offer a promising avenue for generating human beta cells in vitro, advancing diabetes research and modeling.
Area of Science:
- Endocrinology
- Developmental Biology
- Stem Cell Biology
Background:
- Mouse models of pancreatic development and beta cell physiology have limitations for studying human diabetes.
- Differences in pancreatic endocrine cell development and physiology exist between mice and humans.
Purpose of the Study:
- To summarize key differences between mouse and human pancreatic development and beta cell physiology.
- To review progress in modeling human diabetes using human pluripotent stem cells (hPSCs).
- To highlight the need for more physiologically relevant hPSC-derived beta cell models.
Main Methods:
- Literature review comparing mouse and human pancreatic development and physiology.
- Review of recent advancements in hPSC differentiation for beta cell generation.
- Analysis of hPSC-based models for diabetes research.
Main Results:
- Significant disparities exist in pancreatic development and beta cell function between mice and humans.
- hPSC differentiation enables in vitro generation of human beta cells, offering insights into development and disease.
- Current hPSC-derived beta cell models require further refinement for enhanced physiological relevance.
Conclusions:
- hPSC-derived beta cells are a valuable tool for understanding human beta cell biology and modeling diabetes.
- Overcoming limitations in hPSC-derived beta cell models is crucial for advancing diabetes research.
- Future prospects involve developing more accurate and predictive hPSC-based models for human diabetes.
Related Concept Videos
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells
6.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.2K

